# Japanese Phase 1 Multiple Ascending Dose Study

> **NCT01515202** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** BMS-823778
- **DRUG:** Placebo matching with BMS-823778

## Key facts

- **NCT ID:** NCT01515202
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01515202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01515202, "Japanese Phase 1 Multiple Ascending Dose Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01515202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*